title: Re: Paolo Gontero, Richard Sylvester, Francesca Pisano, et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. Eur Urol 2015;67:74-82.
authors.affiliation: Unita' Operativa di Urologia, Ospedale San Raffaele, Milan, Italy. Electronic address: montorsi.francesco@hsr.it.
authors.forename: Francesco
authors.initials: F
authors.lastname: Montorsi
authors.affiliation: Unita' Operativa di Urologia, Ospedale San Raffaele, Milan, Italy.
authors.forename: Giorgio
authors.initials: G
authors.lastname: Gandaglia
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D001500:BCG Vaccine / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology*
chemical_list: D000276:Adjuvants, Immunologic; D001500:BCG Vaccine